494 related articles for article (PubMed ID: 30095672)
21. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
Mazzawi T; Lied GA; Sangnes DA; El-Salhy M; Hov JR; Gilja OH; Hatlebakk JG; Hausken T
PLoS One; 2018; 13(11):e0194904. PubMed ID: 30427836
[TBL] [Abstract][Full Text] [Related]
22. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
[No Abstract] [Full Text] [Related]
23. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
Wang L; Alammar N; Singh R; Nanavati J; Song Y; Chaudhary R; Mullin GE
J Acad Nutr Diet; 2020 Apr; 120(4):565-586. PubMed ID: 31473156
[TBL] [Abstract][Full Text] [Related]
24. No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population.
Hugerth LW; Andreasson A; Talley NJ; Forsberg AM; Kjellström L; Schmidt PT; Agreus L; Engstrand L
Gut; 2020 Jun; 69(6):1076-1084. PubMed ID: 31601615
[TBL] [Abstract][Full Text] [Related]
25. The Development of Irritable Bowel Syndrome: A Prospective Community-Based Cohort Study.
Löwe B; Lohse A; Andresen V; Vettorazzi E; Rose M; Broicher W
Am J Gastroenterol; 2016 Sep; 111(9):1320-9. PubMed ID: 27377523
[TBL] [Abstract][Full Text] [Related]
26. Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome.
Gargari G; Taverniti V; Gardana C; Cremon C; Canducci F; Pagano I; Barbaro MR; Bellacosa L; Castellazzi AM; Valsecchi C; Tagliacarne SC; Bellini M; Bertani L; Gambaccini D; Marchi S; Cicala M; Germanà B; Dal Pont E; Vecchi M; Ogliari C; Fiore W; Stanghellini V; Barbara G; Guglielmetti S
Environ Microbiol; 2018 Sep; 20(9):3201-3213. PubMed ID: 29749705
[TBL] [Abstract][Full Text] [Related]
27. Metabolome-associated psychological comorbidities improvement in irritable bowel syndrome patients receiving a probiotic.
Martin FP; Cominetti O; Berger B; Combremont S; Marquis J; Xie G; Jia W; Pinto-Sanchez MI; Bercik P; Bergonzelli G
Gut Microbes; 2024; 16(1):2347715. PubMed ID: 38717445
[TBL] [Abstract][Full Text] [Related]
28. Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement.
Jacobs JP; Gupta A; Bhatt RR; Brawer J; Gao K; Tillisch K; Lagishetty V; Firth R; Gudleski GD; Ellingson BM; Labus JS; Naliboff BD; Lackner JM; Mayer EA
Microbiome; 2021 Nov; 9(1):236. PubMed ID: 34847963
[TBL] [Abstract][Full Text] [Related]
29. Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress.
Sundin J; Rangel I; Fuentes S; Heikamp-de Jong I; Hultgren-Hörnquist E; de Vos WM; Brummer RJ
Aliment Pharmacol Ther; 2015 Feb; 41(4):342-51. PubMed ID: 25521822
[TBL] [Abstract][Full Text] [Related]
30. Communication between gastrointestinal bacteria and the nervous system.
Bravo JA; Julio-Pieper M; Forsythe P; Kunze W; Dinan TG; Bienenstock J; Cryan JF
Curr Opin Pharmacol; 2012 Dec; 12(6):667-72. PubMed ID: 23041079
[TBL] [Abstract][Full Text] [Related]
31. Mixture model analysis identifies irritable bowel syndrome subgroups characterised by specific profiles of gastrointestinal, extraintestinal somatic and psychological symptoms.
Polster A; Van Oudenhove L; Jones M; Öhman L; Törnblom H; Simrén M
Aliment Pharmacol Ther; 2017 Sep; 46(5):529-539. PubMed ID: 28671338
[TBL] [Abstract][Full Text] [Related]
32. Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis.
Labus JS; Osadchiy V; Hsiao EY; Tap J; Derrien M; Gupta A; Tillisch K; Le Nevé B; Grinsvall C; Ljungberg M; Öhman L; Törnblom H; Simren M; Mayer EA
Microbiome; 2019 Mar; 7(1):45. PubMed ID: 30898151
[TBL] [Abstract][Full Text] [Related]
33. Depression Promotes the Onset of Irritable Bowel Syndrome through Unique Dysbiosis in Rats.
Takajo T; Tomita K; Tsuchihashi H; Enomoto S; Tanichi M; Toda H; Okada Y; Furuhashi H; Sugihara N; Wada A; Horiuchi K; Inaba K; Hanawa Y; Shibuya N; Shirakabe K; Higashiyama M; Kurihara C; Watanabe C; Komoto S; Nagao S; Kimura K; Miura S; Shimizu K; Hokari R
Gut Liver; 2019 May; 13(3):325-332. PubMed ID: 30602220
[TBL] [Abstract][Full Text] [Related]
34. A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles.
Black CJ; Yiannakou Y; Guthrie EA; West R; Houghton LA; Ford AC
Am J Gastroenterol; 2021 Feb; 116(2):372-381. PubMed ID: 33110014
[TBL] [Abstract][Full Text] [Related]
35. Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly
Wu KQ; Sun WJ; Li N; Chen YQ; Wei YL; Chen DF
Scand J Gastroenterol; 2019 Dec; 54(12):1419-1425. PubMed ID: 31765575
[No Abstract] [Full Text] [Related]
36. [Irritable Bowel Syndrome, Emotion Regulation, and Gut Microbiota].
Fukudo S
Brain Nerve; 2016 Jun; 68(6):607-15. PubMed ID: 27279158
[TBL] [Abstract][Full Text] [Related]
37. More than constipation - bowel symptoms in Parkinson's disease and their connection to gut microbiota.
Mertsalmi TH; Aho VTE; Pereira PAB; Paulin L; Pekkonen E; Auvinen P; Scheperjans F
Eur J Neurol; 2017 Nov; 24(11):1375-1383. PubMed ID: 28891262
[TBL] [Abstract][Full Text] [Related]
38. Psychological distress and GI symptoms are related to severity of bloating in women with irritable bowel syndrome.
Park HJ; Jarrett M; Cain K; Heitkemper M
Res Nurs Health; 2008 Apr; 31(2):98-107. PubMed ID: 18181134
[TBL] [Abstract][Full Text] [Related]
39. [Associations of sigmoid colon mucosal mast cells with bowel symptoms and psychological status in patients with irritable bowel syndrome with diarrhea].
Xu D; Chen W; Zhou WX; Wang CD; Fei GJ; Zhu LM; Xin HW; Zhong DR; Sun G; Fang XC
Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(30):2398-403. PubMed ID: 27545031
[TBL] [Abstract][Full Text] [Related]
40. Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation.
Luo M; Liu Q; Xiao L; Xiong LS
J Health Popul Nutr; 2022 May; 41(1):21. PubMed ID: 35578355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
